2025年06月05日 | 国泰君安期货商品研究晨报 | | --- | 观点与策略 | 黄金：小非农超预期走弱 | 3 | | --- | --- | | 白银：跟随反弹 | 3 | | 铜：美元走弱，支撑价格 | 5 | | 铝：震荡横盘 | 7 | | 氧化铝：偏弱运行 | 7 | | 锌：区间调整 | 9 | | 铅：低位企稳 | 10 | | 锡：止跌回升 | 11 | | 镍：短线成本托底，预期偏弱压制 | 13 | | 不锈钢：负反馈与减产博弈，钢价区间震荡 | 13 | | 碳酸锂：基本面暂无改善，反弹空间或有限 | 15 | | 工业硅：情绪扰动，上方空间有限 | 17 | | 多晶硅：弱势基本面格局 | 17 | | 铁矿石：板块预期反复，宽幅震荡 | 19 | | 螺纹钢：市场情绪提振，宽幅震荡 | 20 | | 热轧卷板：市场情绪提振，宽幅震荡 | 20 | | 硅铁：黑色板块共振，宽幅震荡 | 22 | | 锰硅：黑色板块共振，宽幅震荡 | 22 | | 焦炭：三轮提降开启，盘面震荡偏强 | 24 | | 焦煤：消息扰动，盘面震荡偏强 | 24 | | 动力煤：底部阶段企稳运行 | ...

本报记者 吴晓璐 6月3日晚间，浙江嘉化能源化工股份有限公司（以下简称"嘉化能源"）等3家上市公司披露其获得银行回购贷款。据同花 顺iFinD数据统计，截至6月4日，自去年10月份以来，累计607家上市公司披露651单回购增持贷款，贷款金额上限合计1260.25 亿元。 随着政策工具的优化，今年以来，回购增持贷款的参与度和覆盖面进一步提升，中小民企披露的回购增持贷款明显增多， 回购增持再贷款工具对回购增持的"贷"动效应也进一步显现。 南开大学金融学教授田利辉对《证券日报》记者表示，股票回购增持再贷款通过银行的专项资金支持，短期来看，稳定了 市场预期，阻断了外部严峻冲击下的市场负向循环。长期来看，也有助于上市公司资本结构的优化和市场投资理性的形成。一 方面，回购注销减少股本，优化资本结构，提升每股收益。另一方面，增持回购还可推动市场定价更关注企业内在价值，培育 理性投资理念。 年内中小民企披露贷款增多 自从去年10月份股票回购增持再贷款政策工具正式设立以来，民企披露的回购增持贷款的数量和金额一直较高。上述607 家公司中，393家是民企，占比64.74%。这些民企共披露423单回购增持贷款，贷款金额上限合计66 ...

Group 1: Industry Overview - The petroleum and chemical indices mostly rose last week, with the chemical raw materials index down by 0.98%, the chemical machinery index up by 0.83%, the chemical pharmaceuticals index up by 2.47%, and the pesticide and fertilizer index up by 0.71% [1] - In the petroleum sector, the petroleum processing index rose by 0.81%, the petroleum extraction index rose by 1.41%, while the petroleum trade index fell by 7.98% [1] - International crude oil prices experienced narrow fluctuations, with WTI settling at $60.79 per barrel, down 1.20% from May 23, and Brent settling at $63.90 per barrel, down 1.36% [1] Group 2: Market Performance - The top five performing listed chemical companies in the Shanghai and Shenzhen markets last week were Lianhua Technology up by 38.97%, Baismei up by 25.00%, Suqian Liansheng up by 16.80%, Qingdao Jinwang up by 18.23%, and Honghe Technology up by 17.09% [2] - The bottom five performing listed chemical companies were Guangju Energy down by 15.95%, Tianan New Materials down by 14.66%, Hongbaoli down by 13.10%, Annada down by 12.38%, and Heimao Co. down by 12.14% [2] Group 3: Product Price Changes - The top five rising petrochemical products included hydrochloric acid up by 35.42%, liquid chlorine up by 21.85%, glyphosate up by 6.15%, dichloromethane up by 4.36%, and paraquat up by 4.35% [1] - The top five declining petrochemical products included acrylic acid down by 9.74%, butadiene down by 9.60%, natural rubber down by 6.55%, styrene-butadiene rubber down by 6.13%, and aniline down by 5.95% [1]

证券研究报告 | 朝闻国盛 gszqdatemark 2025 06 04 年 月 日 朝闻国盛 论中期分红对股息率的影响 重磅研报 【策略】论中期分红对股息率的影响——20250603 【海外】海外市场—扰动收敛，港股再启程——2025 年 6 月海外金股推 荐——20250603 【策略】6 月策略观点与金股推荐——20250603 【策略】6 月市场观点：关注出口数据反映的关税影响——20250603 【金融工程】六月配置建议：超配 A 股价值风格——20250603 【固定收益】出口运价回升——基本面高频数据跟踪——20250603 今日概览 研究视点 【化工】AI for Science 重磅突破：超级隔热材料问世——20250603 【房地产】2025W22：本周新房成交同比-11.9%，二手房同比+8.9%— —20250603 | 分析师 胡偌碧 | | | | | --- | --- | --- | --- | | 执业证书编号：S0680519010003 | | | | | 邮箱：huruobi@gszq.com | | | | | 行业表现前五名 | | | | | 行业 | 1 月 ...

Core Viewpoint - The company announces a temporary suspension of the conversion of its convertible bonds "齐翔转 2" starting from June 4, 2025, until the record date for the upcoming equity distribution, after which the conversion will resume on the first trading day following the record date [1][2]. Group 1: Bond Information - The bond code is 128128 and the bond name is "齐翔转 2" [1]. - The conversion period for the bonds is from February 26, 2021, to August 19, 2026 [1]. - The suspension of conversion will last from June 4, 2025, until the record date for the equity distribution [1]. Group 2: Conversion Price Adjustment - The company will adjust the conversion price according to the provisions in the bond issuance prospectus when it distributes stock dividends, increases capital, issues new shares, or distributes cash dividends [4]. - The adjustment formulas for the conversion price are provided, detailing how various corporate actions will affect the conversion price [4][5]. - The company will announce any adjustments to the conversion price and the suspension period through official channels, ensuring transparency for bondholders [5].

PTA&MEG早报-2025年6月3日 交易咨询业务资格：证监许可【2012】1091号 PTA 每日观点 大越期货投资咨询部 金泽彬 投资咨询资格证号：Z0015557 联系方式：0575-85226759 重要提示：本报告非期货交易咨询业务项下服务，其中的观点和信息仅作参考之用，不构成对任何人的投资建议。 我司不会因为关注、收到或阅读本报告内容而视相关人员为客户；市场有风险，投资需谨慎。 CONTENTS 目 录 1 前日回顾 2 每日提示 3 4 今日关注 基本面数据 5 PTA： 6、预期：上周PTA装置检修重启并行，PTA自身供需格局尚可，前期持续去库下，当前现货市场流通性偏紧，现货基差偏强运行， 不过下游聚酯工厂减产降负，预计短期内PTA现货价格跟随成本端区间震荡，现货基差维持偏强，关注OPEC+会议结果对油价影 响及聚酯装置变动。 1、基本面：周五，6月中上主港主流在09+220成交，零星在09+215成交，价格商谈区间在4895~5000附近。今日主流现货基差在 09+219。中性 2、基差：现货4940，09合约基差240，盘面贴水 偏多 3、库存：PTA工厂库存4.09天，环比减少0.06 ...

Group 1 - The core viewpoint of the article highlights the ongoing projects of Chizhou Jushi Chemical Co., Ltd., which is planning to produce 250 tons of polyimide monomer and 9000 tons of photoresist through a phased construction approach [1] - The first phase involves the construction of a 250-ton polyimide monomer project, while the second and third phases will focus on 4500 tons of photoresist each [1] - Chizhou Jushi Chemical is a wholly-owned subsidiary of Guangdong Jushi Chemical Co., Ltd., which specializes in the R&D, production, and sales of chemical raw materials and new chemical materials [1] Group 2 - Guangdong Jushi Chemical is also developing the Anqing Juxin high-end new materials project, which covers an area of 300 acres with a total investment of approximately 3 billion yuan, including a 5300 square meter R&D center [1] - The first phase of the project involves a 2 billion yuan investment in a polystyrene project, while the second phase will invest 1.05 billion yuan in electronic chemicals, focusing on LCD display photoresist and polyimide monomer production [1] - The third phase aims to produce 300,000 tons of biodegradable plastics [1] Group 3 - Anqing Juxin New Materials has a subsidiary, Anhui Lavaxi Technology Co., Ltd., established in July 2023, which plans to produce LCD display chemicals and polyimide monomers [2]

Group 1 - The core point of the article is that Jiyuan Holdings Group Co., Ltd. (*ST Jiyuan) will be delisted from the Shenzhen Stock Exchange on May 29, 2025, due to triggering mandatory delisting rules after its stock price remained below 1 yuan for 20 consecutive trading days [1][3] - The company has experienced continuous losses since 2019, with a cumulative net profit loss exceeding 3.2 billion yuan from 2019 to 2023 [3] - Jiyuan Holdings has faced significant goodwill impairment risks, totaling over 1.5 billion yuan from 2019 to 2024, which has directly contributed to its net profit losses [3] Group 2 - The company was originally known as Tonghua Shuanglong Chemical Co., Ltd. and transitioned to the pharmaceutical sector in 2014 through the acquisition of Jinbao Pharmaceutical [3] - Since its rebranding in 2017, the company has aggressively pursued mergers and acquisitions, acquiring over ten companies within three years, leading to a dual business model of "chemicals + pharmaceuticals" [3] - In 2024, the company's revenue declined by 3.69%, and its losses expanded to 439 million yuan [3] Group 3 - As of 2025, a total of 11 companies have been delisted from the A-share market, with *ST Jiyuan being one of them, alongside others like *ST Meixun and *ST Bo Xin [4] - The reasons for delisting include breaches of face value, market value, voluntary delisting applications, and forced delisting due to major violations [4]

Core Viewpoint - Jiyuan Holdings Group Co., Ltd. has been announced to be delisted from the Shenzhen Stock Exchange due to its stock price falling below 1 yuan for twenty consecutive trading days, with the delisting effective on May 29, 2025 [1] Group 1: Company Performance and Financials - Jiyuan Holdings, originally a chemical company, transitioned to the pharmaceutical sector in 2014 through the acquisition of Jinbao Pharmaceutical, establishing a dual business model of "chemicals + pharmaceuticals" [3] - The company engaged in aggressive acquisitions, acquiring over ten companies within three years, with its pharmaceutical segment accounting for 70% of total revenue at its peak, leading to a market capitalization exceeding 5 billion yuan [3] - However, the acquired companies' performance deteriorated post-acquisition, with Zhejiang Yalida Gelatin Co., Ltd. reporting a 94% drop in net profit in 2019, and Changchun Puhua Pharmaceutical Co., Ltd. incurring direct losses [3] - Since 2019, Jiyuan Holdings has been in a continuous loss state, accumulating losses exceeding 3.7 billion yuan [4] Group 2: Attempts at Restructuring and Ownership Changes - The company has made several attempts to change ownership in response to its financial struggles, but all efforts have failed [5] - In 2019, an agreement to transfer shares to Jilin Jisheng Asset Management was terminated due to disagreements on key terms [5] - A proposed acquisition of Xiu Zheng Pharmaceutical was also abandoned due to regulatory uncertainties, leading to scrutiny from the Shenzhen Stock Exchange [5][6] - In 2020, a deal to transfer control to Ben Cao Hui Pharmaceutical faced disputes over payment, resulting in legal proceedings [6]

交易咨询业务资格：证监许可【2012】1091号 PTA&MEG早报-2025年5月29日 大越期货投资咨询部 金泽彬 投资咨询资格证号：Z0015557 联系方式：0575-85226759 重要提示：本报告非期货交易咨询业务项下服务，其中的观点和信息仅作参考之用，不构成对任何人的投资建议。 我司不会因为关注、收到或阅读本报告内容而视相关人员为客户；市场有风险，投资需谨慎。 CONTENTS 目 录 1 前日回顾 2 每日提示 3 4 今日关注 基本面数据 5 PTA 每日观点 PTA： 1、基本面：昨日PTA期货震荡下跌，现货市场商谈氛围一般，贸易商商谈为主，现货基差走强。本周及下周主港货主流在 09+185成交，宁波货在09+178附近商谈成交，价格商谈区间在4835~4925附近。下周仓单在09+180有成交，6月中上仓单在 09+190有成交。今日主流现货基差在09+184。中性 2、基差：现货4865，09合约基差195，盘面贴水 偏多 3、库存：PTA工厂库存4.15天，环比减少0.13天 偏多 4、盘面：20日均线向上，收盘价收于20日均线之上 偏多 5、主力持仓：净多 多增 偏多 6、预期： ...